Ragatz William 4
4 · Viela Bio, Inc. · Filed Mar 4, 2020
Insider Transaction Report
Form 4
Ragatz William
VP, Head of Commercial
Transactions
- Award
Stock Option (Right to Buy)
2020-03-02+50,548→ 50,548 totalExercise: $41.10Exp: 2030-03-01→ Common Stock (50,548 underlying)
Holdings
- 16,250
Common Stock
Footnotes (1)
- [F1]This option grant vests as to 25% of the shares on March 2, 2021 with the remainder vesting in equal installments every three months thereafter and ending on March 2, 2024.